US Equity
GRI
β GRI BIO, INC.GRI Bio, Inc. is a biotechnology company developing novel therapeutics for autoimmune and inflammatory diseases.
π° Market cap: $2.48Mπ 2223 Avenida De La Playa, Suite 208, LA JOLLA, CA, 92037 USπ·οΈ Biotechnology & Medical Researchπ΅ Previous close: $1.45π’ 6,470 credits left
Add Column
All
Trend
| Date βΎ | Close βΎ |
|---|---|
| 2026-07-24 | $1.45 |
| 2026-07-23 | $1.50 |
| 2026-07-22 | $1.48 |
| 2026-07-21 | $1.51 |
| 2026-07-20 | $1.47 |
| 2026-07-17 | $1.50 |
| 2026-07-16 | $1.54 |
| 2026-07-15 | $1.62 |
| 2026-07-14 | $1.57 |
| 2026-07-13 | $1.62 |
| 2026-07-10 | $1.74 |
| 2026-07-09 | $1.78 |
| 2026-07-08 | $1.77 |
| 2026-07-07 | $1.83 |
| 2026-07-06 | $1.81 |
| 2026-07-02 | $1.87 |
| 2026-07-01 | $1.78 |
| 2026-06-30 | $1.77 |
| 2026-06-29 | $1.86 |
| 2026-06-26 | $1.82 |
| 2026-06-25 | $1.96 |
| 2026-06-24 | $1.84 |
| 2026-06-23 | $1.86 |
| 2026-06-22 | $1.87 |
| 2026-06-18 | $1.88 |
| 2026-06-17 | $2.32 |
| 2026-06-16 | $2.17 |
| 2026-06-15 | $2.29 |
| 2026-06-12 | $2.25 |
| 2026-06-11 | $2.31 |
| 2026-06-10 | $2.31 |
| 2026-06-09 | $2.20 |
| 2026-06-08 | $2.17 |
| 2026-06-05 | $2.00 |
| 2026-06-04 | $2.13 |
| 2026-06-03 | $2.01 |
| 2026-06-02 | $2.01 |
| 2026-06-01 | $2.07 |
| 2026-05-29 | $2.06 |
| 2026-05-28 | $2.10 |
| 2026-05-27 | $2.10 |
| 2026-05-26 | $2.04 |
| 2026-05-22 | $2.06 |
| 2026-05-21 | $2.20 |
| 2026-05-20 | $2.20 |
| 2026-05-19 | $2.23 |
| 2026-05-18 | $2.14 |
| 2026-05-15 | $2.03 |
| 2026-05-14 | $2.15 |
| 2026-05-13 | $2.26 |
| 2026-05-12 | $2.28 |
| 2026-05-11 | $2.26 |
| 2026-05-08 | $2.25 |
| 2026-05-07 | $2.25 |
| 2026-05-06 | $2.36 |
| 2026-05-05 | $2.34 |
| 2026-05-04 | $2.26 |
| 2026-05-01 | $2.18 |
| 2026-04-30 | $2.18 |
| 2026-04-29 | $2.23 |
| 2026-04-28 | $2.36 |